Report predicts growth for drug-delivery devices

Mike Verespej

Published: August 31, 2012 6:00 am ET

Related to this story

Topics Medical

BOSTON (Aug. 31, 2:10 p.m. ET) — A new report says that innovation in drug-delivery devices is poised to leap forward after years of incremental growth.

The report, released Aug. 29 by Boston-based Lux Research Inc., said that there is room for more advanced delivery devices including electronic-enabled devices because dozens of blockbuster drugs are coming off patent and many of those drugs only had basic delivery devices, or no delivery device.

“With a flagging drug pipeline and a looming patent cliff for drugs accounting for annual sales of $160 billion, new drug-delivery devices beckon drug-makers looking to shore up revenues,” said analyst Yan Xiang Yang, who was the lead author of the report, “Making Space for Innovation in Drug Delivery Devices.”

“Currently, top-selling drugs worth $124 billion rely on a variety of devices,” she said. “But with innovation increasing in the sector, only $59 billion of these now use advanced drug-delivery devices, while $65 billion worth are still basic devices crying out for an upgrade.”

“We contemplate that truly surprising solutions will appear out of need,” Yang said. “Delivery systems boost safety, efficacy, and sales of drug products. While their use is integral, applications of different delivery systems remain uneven and their full potential unrealized.”

Specifically, Yang sees opportunities for the entry of drug-delivery devices in:

• Therapies for severe conditions—such as cancer, ophthalmic disorders, hematologic disorders, rheumatoid arthritis, and multiple sclerosis—which require intensive and specialized therapies.

• Extended care, where $55 billion worth of frequently or chronically administered therapies rely on basic devices. 

“With the typical value of deliveries within the range of 2 percent to 5 percent of the final drug product, targeting basic-to-advanced deliveries may be looking at a $5 billion market,” she said.

• Markets where patients will expire.

“Over the next five years, 46 percent of the top-selling drugs go off patent,” said Yang. “Alternative delivery devices will not only potentially extend patent protection, but can also draw in customers to help grow, maintain, or at least minimize the loss of market share.”


Comments

Report predicts growth for drug-delivery devices

Mike Verespej

Published: August 31, 2012 6:00 am ET

Post Your Comments


Back to story


More stories

Medical manufacturer adds clean room, machinery

August 1, 2014 8:39 am ET

Medical component maker UFP Technologies Inc. expanded its Georgetown, Mass., operation with the addition of a clean room and high volume equipment.    More

Image

Tessy investing $10 million in new plant, infrastructure

July 30, 2014 4:57 pm ET

Tessy Plastics Corp. continues to buy factory buildings in upstate New York — acquiring a 112,000-square-foot former Honeywell building in...    More

Image

Two medical device makers add specialty products through acquisitions

July 28, 2014 3:02 pm ET

The medical merger mania continues this summer as two more medical device manufacturers are swallowed up by bigger competitors.    More

Image

RxFiber developing new generation of medical fibers

July 23, 2014 1:38 pm ET

Increased concern about patient safety is creating a business opportunity for biomaterial fibers maker RxFiber LLC.    More

Market Reports

Pipe, Profile & Tubing Extrusion in North America 2014

U.S. demand for extruded plastics is expected to grow by 3 percent in 2014, with PVC remaining the largest segment.

Plastic pipe will post the strongest gains through 2018, continuing to take market share from competing materials in a range of markets.

Our latest market report provides in-depth analysis of current trends and their financial impact on the pipe, profile and tubing extrusion industry in North America.

Learn more

2014 Injection Molding Industry Report

GROWTH, OPPORTUNITY IN SIGHT FOR INJECTION MOLDERS IN 2014

In the wake of the economic turbulence earlier in this decade, molders today find themselves in much better shape. Molders are gaining a competitive advantage by investing in people, equipment and seeking inroads into new markets on a global scale.

Growth in the injection molding industry is going to be driven by low financing costs and a continued move to reshore some business.

Learn more

Shale Gas Market - Analysis of North American Region

This report highlights the impact of shale-based natural gas on the North American plastics market and features an in-depth analysis of production trends in the United States during 2013 and a forecast for 2014 and beyond.

Learn more

Upcoming Plastics News Events

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events